Narcolepsy - Bronson Healthcare

Narcolepsy

A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects with Narcolepsy with Cataplexy

About this Study

Principal Investigator:

Participation Eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Study Status:

  • Currently Enrolling

Study IDs

ClinicalTrials.gov Identifier:

Sponsor:

  • Jazz Pharmaceuticals

Participating Locations


This study is currently closed to enrollments. If you would like additional information, please contact the research team at the Bronson Neuroscience Center at (269) 341-8588 or neuroscienceresearch@bronsonhg.org.